Fortis Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $534K | Hold |
1,065
| – | – | 0.25% | 64 |
|
|
2026
Q1 | $523K | Hold |
1,065
| – | – | 0.26% | 63 |
|
|
2025
Q4 | $617K | Hold |
1,065
| – | – | 0.33% | 54 |
|
|
2025
Q3 | $517K | Sell |
1,065
-625
| -37% | -$291K | 0.29% | 58 |
|
|
2025
Q2 | $685K | Sell |
1,690
-17
| -1% | -$7.11K | 0.44% | 43 |
|
|
2025
Q1 | $849K | Buy |
1,707
+150
| +10% | +$81.2K | 0.55% | 35 |
|
|
2024
Q4 | $810K | Buy |
1,557
+17
| +1% | +$9.35K | 0.53% | 36 |
|
|
2024
Q3 | $953K | Hold |
1,540
| – | – | 0.62% | 34 |
|
|
2024
Q2 | $852K | Hold |
1,540
| – | – | 0.6% | 32 |
|
|
2024
Q1 | $895K | Hold |
1,540
| – | – | 0.6% | 34 |
|
|
2023
Q4 | $817K | Buy |
1,540
+70
| +5% | +$33.9K | 0.58% | 34 |
|
|
2023
Q3 | $744K | Hold |
1,470
| – | – | 0.56% | 35 |
|
|
2023
Q2 | $767K | Hold |
1,470
| – | – | 0.55% | 29 |
|
|
2023
Q1 | $847K | Buy |
1,470
+150
| +11% | +$84.5K | 0.55% | 30 |
|
|
2022
Q4 | $727K | Hold |
1,320
| – | – | 0.55% | 29 |
|
|
2022
Q3 | $669K | Buy |
1,320
+50
| +4% | +$28K | 0.48% | 36 |
|
|
2022
Q2 | $690K | Buy |
1,270
+125
| +11% | +$68.8K | 0.46% | 35 |
|
|
2022
Q1 | $676K | Sell |
1,145
-154
| -12% | -$88.5K | 0.37% | 41 |
|
|
2021
Q4 | $867K | Hold |
1,299
| – | – | 0.5% | 36 |
|
|
2021
Q3 | $742K | Sell |
1,299
-125
| -9% | -$68.6K | 0.45% | 39 |
|
|
2021
Q2 | $718K | Buy |
1,424
+554
| +64% | +$261K | 0.41% | 45 |
|
|
2021
Q1 | $397K | Sell |
870
-47
| -5% | -$22.4K | 0.28% | 53 |
|
|
2020
Q4 | $427K | Hold |
917
| – | – | 0.38% | 40 |
|
|
2020
Q3 | $405K | Sell |
917
-30
| -3% | -$12.4K | 0.38% | 34 |
|
|
2020
Q2 | $343K | Sell |
947
-43
| -4% | -$14.4K | 0.34% | 42 |
|
|
2020
Q1 | $281K | Buy |
990
+668
| +207% | +$211K | 0.19% | 58 |
|
|
2019
Q4 | $105K | Buy |
322
+77
| +31% | +$23.3K | 0.06% | 174 |
|
|
2019
Q3 | $71K | Hold |
245
| – | – | 0.03% | 197 |
|
|
2019
Q2 | $72K | Hold |
245
| – | – | 0.04% | 206 |
|
|
2019
Q1 | $67K | Sell |
245
-50
| -17% | -$12.4K | 0.04% | 200 |
|
|
2018
Q4 | $66K | Hold |
295
| – | – | 0.04% | 194 |
|
|
2018
Q3 | $72K | Hold |
295
| – | – | 0.04% | 181 |
|
|
2018
Q2 | $61K | Buy |
295
+245
| +490% | +$52K | 0.04% | 191 |
|
|
2018
Q1 | $10K | Hold |
50
| – | – | 0.01% | 246 |
|
|
2017
Q4 | $9K | Hold |
50
| – | – | 0.01% | 238 |
|
|
2017
Q3 | $9K | Buy |
+50
| New | +$9.05K | 0.01% | 238 |
|
Other funds holding TMO
Fortis Advisors's TMO Position: Q2 2026 in Review
Fortis Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,065 shares worth $534K. The position accounts for 0.25% of the portfolio, ranked #64.
Fortis Advisors first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $953K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Fortis Advisors held 1,065 shares of Thermo Fisher Scientific worth $534K as of Q2 2026.
- Fortis Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.25% of Fortis Advisors's portfolio in Q2 2026, its #64 holding.
- Fortis Advisors first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
- Fortis Advisors's Thermo Fisher Scientific position peaked at $953K in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Fortis Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.